The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Ethyl 2-(3-Cyanophenyl)-4-methyl-1-[(4-nitrobenzyl)oxy]-1H-imidazole-5-carboxylate ID: ALA4762718
PubChem CID: 162660254
Max Phase: Preclinical
Molecular Formula: C21H18N4O5
Molecular Weight: 406.40
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCOC(=O)c1c(C)nc(-c2cccc(C#N)c2)n1OCc1ccc([N+](=O)[O-])cc1
Standard InChI: InChI=1S/C21H18N4O5/c1-3-29-21(26)19-14(2)23-20(17-6-4-5-16(11-17)12-22)24(19)30-13-15-7-9-18(10-8-15)25(27)28/h4-11H,3,13H2,1-2H3
Standard InChI Key: LHRXMXQZCWZXOD-UHFFFAOYSA-N
Molfile:
RDKit 2D
30 32 0 0 0 0 0 0 0 0999 V2000
33.1856 -21.1479 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.1845 -21.9674 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.8925 -22.3764 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.6022 -21.9669 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.5994 -21.1443 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.8907 -20.7390 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.3033 -20.7347 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.0511 -21.0642 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
36.5956 -20.4549 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.1843 -19.7487 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.3857 -19.9217 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
37.4086 -20.5372 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.5138 -19.0008 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.3262 -18.9123 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
36.0309 -18.3416 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
37.6557 -18.1645 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.4681 -18.0759 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.8953 -23.1896 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.8951 -24.0067 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.7763 -19.3772 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.0001 -19.6327 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.3907 -19.0882 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.5610 -18.2919 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.9525 -17.7477 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.1753 -18.0030 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.0101 -18.8077 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.6200 -19.3484 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.5646 -17.4582 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.7887 -17.7147 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.7304 -16.6580 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 7 1 0
5 7 1 0
9 12 1 0
10 13 1 0
13 14 1 0
13 15 2 0
14 16 1 0
16 17 1 0
18 19 3 0
3 18 1 0
11 20 1 0
20 21 1 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 22 1 0
28 29 2 0
28 30 1 0
25 28 1 0
M CHG 2 28 1 30 -1
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 406.40Molecular Weight (Monoisotopic): 406.1277AlogP: 3.44#Rotatable Bonds: 7Polar Surface Area: 120.28Molecular Species: NEUTRALHBA: 8HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 9HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 2.21CX LogP: 3.52CX LogD: 3.52Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.33Np Likeness Score: -1.60
References 1. Lei Y,Zhang B,Liu D,Zhao J,Dai X,Gao J,Mao Q,Feng Y,Zhao J,Lin F,Duan Y,Zhang Y,Bao Z,Yang Y,Mou Y,Wang S. (2020) Switching a Xanthine Oxidase Inhibitor to a Dual-Target Antagonist of P2Y and P2Y as an Oral Antiplatelet Agent with a Wider Therapeutic Window in Rats than Ticagrelor., 63 (24): [PMID:33307675 ] [10.1021/acs.jmedchem.0c01524 ]